Your browser doesn't support javascript.
loading
The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders.
Cohen, A T; Imfeld, S; Markham, J; Granziera, S.
Affiliation
  • Cohen AT; Department of Haematological Medicine, Guy's and St Thomas' Hospitals, London, UK. Electronic address: alexander.cohen@kcl.ac.uk.
  • Imfeld S; Vascular Medicine, King's College Hospital, London, UK; Department of Angiology, University Hospital Basel, Switzerland.
  • Markham J; Vascular Medicine, King's College Hospital, London, UK.
  • Granziera S; Vascular Medicine, King's College Hospital, London, UK; University of Padova, Department of Medicine (DIMED), Padova, Italy.
Thromb Res ; 135(2): 217-25, 2015 Feb.
Article in En | MEDLINE | ID: mdl-25541030
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Primary Prevention / Platelet Aggregation Inhibitors / Cardiovascular Diseases / Venous Thromboembolism / Secondary Prevention Type of study: Guideline Limits: Humans Language: En Journal: Thromb Res Year: 2015 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Primary Prevention / Platelet Aggregation Inhibitors / Cardiovascular Diseases / Venous Thromboembolism / Secondary Prevention Type of study: Guideline Limits: Humans Language: En Journal: Thromb Res Year: 2015 Document type: Article Country of publication: Estados Unidos